Vivos Therapeutics Inc.

NASDAQ: VVOS · Real-Time Price · USD
4.61
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
4.37
-5.21%
Pre-market: Aug 15, 2025, 08:40 AM EDT

Vivos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.14M -13.58M -23.84M -20.29M
Depreciation & Amortization
581K 621K 669K 733K
Stock-Based Compensation
762K 1.84M 2.4M 2.66M
Other Working Capital
-1.66M 1.88M 474K -507K
Other Non-Cash Items
42K -3.57M -518K -9K
Deferred Income Tax
n/a n/a n/a 1.14M
Change in Working Capital
-2.94M 2.86M 1.71M 28K
Operating Cash Flow
-12.69M -11.95M -19.59M -15.73M
Capital Expenditures
-568K -803K -924K -2.4M
Cash Acquisitions
n/a n/a n/a -225K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-568K n/a -924K 13K
Investing Cash Flow
-568K -853K -924K -2.61M
Debt Repayment
n/a n/a n/a -25K
Common Stock Repurchased
n/a n/a n/a -1.5M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
10.08M 6.92M n/a -2.24M
Financial Cash Flow
17.88M 10.92M n/a 24.17M
Net Cash Flow
4.62M -1.88M -20.51M 5.82M
Free Cash Flow
-13.26M -12.75M -20.51M -18.13M